Zimmer Biomet to acquire Monogram Technologies for $177 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026


Go back to Zimmer Biomet to acquire Monogram Technologies for $177 million

BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH)

July 14, 2025 12:17 PM UTC

BTIG analyst Ryan Zimmerman reiterated a Buy rating and $117.00 price target on Zimmer Biomet (NYSE: ZBH).

The analyst comments "This morning, ZBH announced it has entered into a definitive agreement to acquire Monogram Technologies (MGRM, Not Rated) for $4.04 per share, equity value of ~$177M and enterprise value of ~$168M. The transaction also features a CVR worth up to $12.37 per share if all milestones are achieved... More